companydata.dkSelma Diagnostics ApS: Financial statements 2019
CVR: 36961376
Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,931,165 and a net result of DKK -2,749,909 compared with DKK -2,588,588 the year before. Equity amounted to DKK 414,895. The solvency ratio was 32.9%. The company had 3 employees in the financial year.
- Gross Profit
- -1,931,165 kr.
- Profit/Loss
- -2,749,909 kr.
- Equity
- 414,895 kr.
- Total Assets
- 1,261,032 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1.9 mio. | -2.7 mio. | 415 t. | 3 |
| 2018 | - | -1.7 mio. | -2.6 mio. | 1.5 mio. | 3 |
| 2017 | - | -1.9 mio. | -2.3 mio. | 4.1 mio. | 2 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Selma Diagnostics ApS has published its annual report for 2018. Gross profit came to DKK -1,662,659, and the net result was DKK -2,588,588.
As of June 3, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Selma Diagnostics ApS.
About Selma Diagnostics ApS
Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity amounted to DKK -11,154,823.